ICM was established in 2012 as a subsidiary of Yonsei Technology Holdings.
ICM is developing novel “First-in-Class” gene therapies for incurable Diseases.
ICM stands for “Innovative Cure in Medicine”.
The LOGO symbolizes “Globe” and “Bio”, which conveys our dreams for “Global Biotech Company”.
The color of CI signifies “Healing, Cure, and Rejuvenation”.